Gradientech: Gisela Sitbon, Rolf Ehrnström, Simon Turner

Gradientech has added three new board members: Gisela Sitbon, Rolf Ehrnström, and Simon Turner. Sitbon boasts more than 25 years of senior level life science experience and will be the new chair of the board at the Uppsala, Sweden-based developer of rapid phenotypic antibiotic suceptibility testing. Ehrnström, meanwhile, has experience in research and development at companies such as Amersham Pharmacia Biotech, Dako, and Gyros, while Turner is an investment analyst.